Skip to content

AMERICAN BIO MEDICA CORP

Delisted

CIK 896747fmd_12KX78R7HX9NNZDE5TXMAJES8GManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2010 to Mar 31, 2023, 52 periods

Income Statement · Annual · Millions · USD
Line itemFY2013FY2014FY2015FY2016FY2017FY2018FY2019FY2020FY2021FY2022
Total interest income––––000–––
Total revenues––––544421
Cost of revenue5433332321
Net interest income––––(0)(0)(0)–––
Gross profit433221111(0)
Research and development1000000000
Selling, general and administrative4333222221
Total operating expenses––33222221
Operating income(1)(0)(0)(0)(0)(1)(1)(1)(1)(1)
Interest expense0000000000
Interest and investment income00––––––––
Other non-operating income (expense)1–(0)(0)(0)(0)(0)(0)1(0)
Income before taxes(1)(0)(0)(0)(1)(1)(1)(1)(0)(1)
Income tax expense000000(0)000
Net income from continuing operations(1)(0)(0)(0)(1)(1)(1)(1)(0)(1)
Net income(1)(0)(0)(0)(1)(1)(1)(1)(0)(1)
AMERICAN BIO MEDICA CORP financial statements · FinancialMD